Lv11
20 积分 2024-07-23 加入
Efficacy and Safety of Sodium‐Glucose Co‐Transporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events and Safety Outcomes in Patients with Systemic Lupus Erythematosus and Comorbid Type 2 Diabetes: A Population‐based Target Trial Emulation
2小时前
已完结
O-GlcNAcylation of cardiac Nav1.5 contributes to the development of arrhythmias in diabetic hearts
23天前
已完结
Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes
23天前
已完结
Molecular mechanisms of O-GlcNAcylation
23天前
已完结
O-GlcNAc modification of transcription factors, glucose sensing and glucotoxicity
23天前
已完结
Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics
23天前
已完结
Protein O-GlcNAcylation: emerging mechanisms and functions
1个月前
已完结
Neuregulin-1/ErbBs信号通路在慢性心力衰竭中的研究进展
1个月前
已完结
Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian Cancer
1个月前
已完结
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
1个月前
已完结
皖公网安备34019202002308
